3.9 Review

Myotubularins and associated neuromuscular diseases

Journal

CLINICAL LIPIDOLOGY
Volume 7, Issue 2, Pages 151-162

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/CLP.12.7

Keywords

centronuclear myopathy; Charcot-Marie-Tooth neuropathy; MTMR; myotubular myopathy; myotubularin; phosphoinositide

Funding

  1. ERA-Net for research programs on rare diseases (E-rare)
  2. Association francaise contre les Myopathies (AFM)
  3. Italian Telethon
  4. Institut National de la Sante et de la Recherche Medicale
  5. Agence Nationale de la Recherche
  6. Telethon

Ask authors/readers for more resources

The myotubularins are a family of phosphoinositide 3-phosphatases preferentially hydrolyzing phosphatidylinositol 3-monophosphate and also phosphatidylinositol (3,5) bis-phosphate, thus generating phosphatidylinositol and phosphatidylinositol 5-monophosphate, respectively. These phosphoinositides are known regulators of vesicular trafficking and phosphatidylinositol 5-monophosphate was also implicated in signal transduction regulation. Based on their capacity to control the level of these phosphoinositides, myotubularins are involved in the regulation of vesicular trafficking, membrane homeostasis, cytoskeleton dynamics, proliferation and apoptosis. Myotubularin dysfunctions are linked to genetic diseases: MTMI is mutated in the X-linked congenital myotubular myopathy and MTMR2 and MTMR13 are mutated in autosomal recessive type 4B1 and 4B2 Charcot-Marie-Tooth neuropathies, respectively. This review presents the cellular functions of myotubularins and highlights their physiopathological roles in neuromuscular diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available